Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells - PubMed (original) (raw)
. 2006 Jun 1;66(11):5934-40.
doi: 10.1158/0008-5472.CAN-05-3197.
Rui Zhan, Ying Wang, Sudha K Pai, Shigeru Hirota, Sadahiro Hosobe, Yukio Takano, Ken Saito, Eiji Furuta, Megumi Iiizumi, Sonia Mohinta, Misako Watabe, Charles Chalfant, Kounosuke Watabe
Affiliations
- PMID: 16740734
- DOI: 10.1158/0008-5472.CAN-05-3197
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells
Sucharita Bandyopadhyay et al. Cancer Res. 2006.
Abstract
Fatty acid synthase (FAS) has been found to be overexpressed in a wide range of epithelial tumors, including breast cancer. Pharmacologic inhibitors of FAS cause apoptosis of breast cancer cells and result in decreased tumor size in vivo. However, how the inhibition of FAS induces apoptosis in tumor cells remains largely unknown. To understand the apoptotic pathway resulting from direct inhibition of FAS, we treated breast tumor cells with or without FAS small interfering RNA (siRNA) followed by a microarray analysis. Our results indicated that the proapoptotic genes BNIP3, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and death-associated protein kinase 2 (DAPK2) were significantly up-regulated on direct inhibition of the FAS gene. We also found that the knockdown of FAS expression significantly increased ceramide level in the tumor cells, and this increase was abrogated by acetyl-CoA carboxylase inhibitor. In addition, carnitine palmitoyltransferase-1 (CPT-1) inhibitor up-regulated the ceramide and BNIP3 levels in these cells, whereas treatment of tumor cells with FAS siRNA in the presence of a ceramide synthase inhibitor abrogated the up-regulation of BNIP3 and inhibited apoptosis. Furthermore, we found that treatment of cells with BNIP3 siRNA significantly counteracted the effect of FAS siRNA-mediated apoptosis. Consistent with these results, a significant inverse correlation was observed in the expression of FAS and BNIP3 in clinical samples of human breast cancer. Collectively, our results indicate that inhibition of FAS in breast cancer cells causes accumulation of malonyl-CoA, which leads to inhibition of CPT-1 and up-regulation of ceramide and induction of the proapoptotic genes BNIP3, TRAIL, and DAPK2, resulting in apoptosis.
Similar articles
- Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou W, Simpson PJ, McFadden JM, Townsend CA, Medghalchi SM, Vadlamudi A, Pinn ML, Ronnett GV, Kuhajda FP. Zhou W, et al. Cancer Res. 2003 Nov 1;63(21):7330-7. Cancer Res. 2003. PMID: 14612531 - Fatty acid synthase: a metabolic oncogene in prostate cancer?
Baron A, Migita T, Tang D, Loda M. Baron A, et al. J Cell Biochem. 2004 Jan 1;91(1):47-53. doi: 10.1002/jcb.10708. J Cell Biochem. 2004. PMID: 14689581 Review. - Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
Menendez JA, Lupu R. Menendez JA, et al. Arch Immunol Ther Exp (Warsz). 2004 Nov-Dec;52(6):414-26. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15577743 Review.
Cited by
- Lipid Alterations in Glioma: A Systematic Review.
Abdul Rashid K, Ibrahim K, Wong JHD, Mohd Ramli N. Abdul Rashid K, et al. Metabolites. 2022 Dec 16;12(12):1280. doi: 10.3390/metabo12121280. Metabolites. 2022. PMID: 36557318 Free PMC article. Review. - Effects of gossypol on apoptosis‑related gene expression in racially distinct triple‑negative breast cancer cells.
Messeha SS, Zarmouh NO, Mendonca P, Alwagdani H, Cotton C, Soliman KFA. Messeha SS, et al. Oncol Rep. 2019 Aug;42(2):467-478. doi: 10.3892/or.2019.7179. Epub 2019 May 31. Oncol Rep. 2019. PMID: 31173249 Free PMC article. - Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds.
Rabionet M, Polonio-Alcalá E, Relat J, Yeste M, Sims-Mourtada J, Kloxin AM, Planas M, Feliu L, Ciurana J, Puig T. Rabionet M, et al. Mater Today Bio. 2021 Nov 16;12:100155. doi: 10.1016/j.mtbio.2021.100155. eCollection 2021 Sep. Mater Today Bio. 2021. PMID: 34841239 Free PMC article. - Inhibition of SREBP1 sensitizes cells to death ligands.
Eberhard Y, Gronda M, Hurren R, Datti A, MacLean N, Ketela T, Moffat J, Wrana JL, Schimmer AD. Eberhard Y, et al. Oncotarget. 2011 Mar;2(3):186-96. doi: 10.18632/oncotarget.239. Oncotarget. 2011. PMID: 21406729 Free PMC article. - The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.
Kwan HY, Yang Z, Fong WF, Hu YM, Yu ZL, Hsiao WL. Kwan HY, et al. J Gastroenterol. 2013 Feb;48(2):182-92. doi: 10.1007/s00535-012-0612-1. Epub 2012 Jun 23. J Gastroenterol. 2013. PMID: 22722903
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous